Tracy Warren

Tracy Warren serves as general partner of Astarte Ventures, an early stage venture firm focused on women’s & children’s health & wellbeing. Currently, Tracy also serves as a general partner of Battelle Ventures and its affiliate fund, Innovation Valley Partners, for which she focuses on investments in health & life sciences.

Tracy has led investments in NuPathe, which completed its IPO in 2010 and was subsequently acquired by Teva Pharmaceuticals. She currently serves as Chairman of BioNano Genomics & on the Board of Micro Interventional Devices.

Alongside Dr. Cymbeline Culiat, Ms. Warren co-founded NellOne Therapeutics, a soft-tissue regenerative medicine company based on the NELL1 gene and Dr. Culiat’s work at Oak Ridge National Lab. As CEO, she leads the company’s efforts with respect to strategy, fundraising, & business development.